Solution Spotlight: IQVIA Market Access Launch Pad

IQVIA Market Access Launch Pad is a dynamic and comprehensive suite of tools designed to support pharmaceutical companies in their product launch readiness. It integrates policy structure updates, project tracking, and account readiness assessments to ensure a successful and well-coordinated launch. The suite includes three main components: the Workshop, the Project Tracker, and the Account Readiness Heatmap.

What problem or status quo deficiency are you solving?

The transformation of the NHS – and the pace with which these changes are taking place – is unprecedented. As a consequence, life sciences and medical device manufacturers are preparing to launch their products into an uncertain environment with imperfect information. The Market Access Launch Pad seeks to equip our clients with the information and insights to systematically prepare for a successful launch, gaining deep knowledge into local system readiness.

What has made this problem challenging to address in the past?

Whilst launching a product into the NHS is complex, it is the present that is posing the greatest challenge. Due to the uncertainties that lay ahead for the NHS, our life sciences clients face considerable challenges in gaining the clarity needed to navigate this variability around their product launch.

What new innovations does your solution bring to bear on these challenges?

By combining expert insights, established NHS relationships, and our advanced data capabilities, IQVIA’s solution enables life sciences organisations to unify qualitative and quantitative data into a clear view of system readiness. The baseline “heatmap” of system readiness can then be used to quantify the impact the life sciences company is having on addressing these challenges pre- and post-launch.

How does your solution work?

1. Workshop:

Purpose: Provides a structured overview of the current policy environment and updates relevant to the pharmaceutical industry.
Content: Includes insights into the NHS landscape, commissioning changes, and strategic considerations for launch readiness.
Application: Helps clients understand the macro-level changes and their impact on product launch, facilitating informed decision-making and strategic planning.

2. Project Tracker:

Purpose: Maps out key stages of the product launch, detailing what information is needed at each stage.
Content: Includes timelines, key dates, events, project categories, ownership, and completion status.
Application: Offers a clear and organised view of the launch process, ensuring all critical tasks are tracked and managed effectively. It helps teams stay aligned and focused on their objectives, providing a transparent overview of progress and upcoming milestones.

3. Account Readiness Heatmap:

Purpose: Assesses the readiness of individual accounts using both qualitative and quantitative data.
Content: Combines data from various sources, public, IQVIA proprietary, and data internal to the manufacturer, to create a comprehensive view of account readiness.
Application: Provides a heatmap to identify hotspots and areas needing support, allowing for targeted account planning. The tool includes the ability to weight different parts of the score, enabling clients to prioritise specific variables and adjust their strategies accordingly. It is designed to be dynamic and updatable, reflecting new insights and data as they become available.

IQVIA readiness heat map

What makes your solution stand out in the market?

Our solution provides a comprehensive view of the NHS landscape regarding launch readiness, in particular the combination of qualitative and quantitative data to generate our unique weighted scoring mechanism of launch readiness.

What concrete outcomes and KPI benefits does your solution deliver?

The solution seeks to de-risk the manufacturer’s market access launch activities, by providing deep sub-national insight to our life science clients, ensuring they are equipped to make the most accurate launch decisions. The primary key performance indicator is therefore a successful launch of the product.

How does your solution improve the experience for the end user?

Enhanced decision-making: Provides a structured and data-driven approach to launch planning, facilitating informed decisions.
Improved coordination: Ensures all teams are aligned and focused on their objectives, reducing the risk of oversight and miscommunication.
Targeted support: Identifies areas needing additional support, allowing for more effective resource allocation and strategic planning.
Transparency and accountability: Offers a clear and organised view of progress, ensuring all stakeholders are aware of their responsibilities and deadlines.

What do your customers have to say about this solution?

IQVIA Market Access Launch Pad has supported many customers to launch successfully in an uncertain environment. Customers have responded positively, as they have moved between franchises and even companies, we have been requested to deliver this solution as those individuals deemed it so vital to launch success in their previous company.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialisation of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analysing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviours and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.